Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stieber

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Anticancer Research|September 2, 1999
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysisF C Ebeling, U M Schmitt, M Untch, et al.
Annals of the New York Academy of Sciences|November 16, 2001
Circulating nucleosomes in serumS Holdenrieder, P Stieber, H Bodenmüller, et al.
Anticancer Research|September 2, 1999
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseasesU Hasholzner, P Stieber, A Zimmermann, et al.
Urology|August 1, 1995
Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancerC M Schambeck, N Schmeller, P Stieber, et al.
Clinical Biochemistry|August 1, 1993
Cytokeratin 19 fragments: a new marker for non-small-cell lung cancerP Stieber, H Bodenmüller, D Banauch, et al.
Cancer|August 1, 1993
CYFRA 21-1. A new marker in lung cancerP Stieber, U Hasholzner, H Bodenmüller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancerG Konecny, M Untch, A Pihan, et al.
Anticancer Research|September 2, 1999
BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?B Mahnert, S Tauber, M Kriegmair, et al.
The International Journal of Biological Markers|July 29, 1998
The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable diseaseA Van Dalen, V Barak, A Cremaschi, et al.
Anticancer Research|May 18, 2012
Cytokeratin serum biomarkers in patients with colorectal cancerS Holdenrieder, P Stieber, V Liska, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Anticancer Research|September 2, 1999
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysisF C Ebeling, U M Schmitt, M Untch, et al.
Annals of the New York Academy of Sciences|November 16, 2001
Circulating nucleosomes in serumS Holdenrieder, P Stieber, H Bodenmüller, et al.
Anticancer Research|September 2, 1999
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseasesU Hasholzner, P Stieber, A Zimmermann, et al.
Urology|August 1, 1995
Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancerC M Schambeck, N Schmeller, P Stieber, et al.
Clinical Biochemistry|August 1, 1993
Cytokeratin 19 fragments: a new marker for non-small-cell lung cancerP Stieber, H Bodenmüller, D Banauch, et al.
Cancer|August 1, 1993
CYFRA 21-1. A new marker in lung cancerP Stieber, U Hasholzner, H Bodenmüller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancerG Konecny, M Untch, A Pihan, et al.
Anticancer Research|September 2, 1999
BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?B Mahnert, S Tauber, M Kriegmair, et al.
The International Journal of Biological Markers|July 29, 1998
The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable diseaseA Van Dalen, V Barak, A Cremaschi, et al.
Anticancer Research|May 18, 2012
Cytokeratin serum biomarkers in patients with colorectal cancerS Holdenrieder, P Stieber, V Liska, et al.
Pageof 9